Volgen
Joke Bilcke
Joke Bilcke
Center for Health Economics Research and Modeling of Infectious Diseases, University of Antwerp
Geverifieerd e-mailadres voor uantwerp.be
Titel
Geciteerd door
Geciteerd door
Jaar
Rotavirus disease and vaccination: impact on genotype diversity
J Matthijnssens, J Bilcke, M Ciarlet, V Martella, K Bányai, M Rahman, ...
Future microbiology 4 (10), 1303-1316, 2009
3642009
Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015)
L Willem, F Verelst, J Bilcke, N Hens, P Beutels
BMC infectious diseases 17, 1-16, 2017
1972017
Accounting for methodological, structural, and parameter uncertainty in decision-analytic models: a practical guide
J Bilcke, P Beutels, M Brisson, M Jit
Medical Decision Making 31 (4), 675-692, 2011
1842011
Cost of respiratory syncytial virus-associated acute lower respiratory infection management in young children at the regional and global level: a systematic review and meta …
S Zhang, LZ Akmar, F Bailey, BA Rath, M Alchikh, B Schweiger, ...
The Journal of infectious diseases 222 (Supplement_7), S680-S687, 2020
1762020
Biomass production efficiency controlled by management in temperate and boreal ecosystems
M Campioli, S Vicca, S Luyssaert, J Bilcke, E Ceschia, FS Chapin III, ...
Nature geoscience 8 (11), 843-846, 2015
1582015
Methods for health economic evaluation of vaccines and immunization decision frameworks: a consensus framework from a European vaccine economics community
B Ultsch, O Damm, P Beutels, J Bilcke, B Brüggenjürgen, A Gerber-Grote, ...
Pharmacoeconomics 34, 227-244, 2016
1282016
Detection of human papillomavirus DNA in urine. A review of the literature
A Vorsters, I Micalessi, J Bilcke, M Ieven, J Bogers, P Van Damme
European journal of clinical microbiology & infectious diseases 31, 627-640, 2012
1152012
The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe
M Jit, J Bilcke, MJJ Mangen, H Salo, H Melliez, WJ Edmunds, Y Yazdan, ...
Vaccine 27 (44), 6121-6128, 2009
1152009
The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom
AJ Van Hoek, A Melegaro, N Gay, J Bilcke, WJ Edmunds
Vaccine 30 (6), 1225-1234, 2012
872012
Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 …
X Li, L Willem, M Antillon, J Bilcke, M Jit, P Beutels
BMC medicine 18, 1-16, 2020
862020
Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study
J Bilcke, M Antillón, Z Pieters, E Kuylen, L Abboud, KM Neuzil, AJ Pollard, ...
The Lancet Infectious Diseases 19 (7), 728-739, 2019
842019
The health and economic burden of chickenpox and herpes zoster in Belgium
J Bilcke, B OGUNJIMI, C Marais, F De Smet, M Callens, K Callaert, ...
Epidemiology & Infection 140 (11), 2096-2109, 2012
732012
Cost-Effectiveness of Rotavirus Vaccination: Exploring Caregiver (s) and``No Medical Care''Disease Impact in Belgium
J Bilcke, P Van Damme, P Beutels
Medical Decision Making 29 (1), 33-50, 2009
732009
Influenza-like-illness and clinically diagnosed flu: disease burden, costs and quality of life for patients seeking ambulatory care or no professional care at all
J Bilcke, S Coenen, P Beutels
PloS one 9 (7), e102634, 2014
722014
Reviewing the cost effectiveness of rotavirus vaccination: the importance of uncertainty in the choice of data sources
J Bilcke, P Beutels
Pharmacoeconomics 27, 281-297, 2009
702009
Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low-and middle-income settings
M Antillón, J Bilcke, AD Paltiel, VE Pitzer
Vaccine 35 (27), 3506-3514, 2017
652017
Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014
M Sabbe, N Berger, A Blommaert, B Ogunjimi, T Grammens, M Callens, ...
Eurosurveillance 21 (27), 30273, 2016
652016
Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysis
J Bilcke, P Van Damme, M Van Ranst, N Hens, M Aerts, P Beutels
PloS one 4 (6), e6060, 2009
632009
Childhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting?
J Bilcke, A Jan van Hoek, P Beutels
Human vaccines & immunotherapeutics 9 (4), 812-822, 2013
572013
Did large-scale vaccination drive changes in the circulating rotavirus population in Belgium?
VE Pitzer, J Bilcke, E Heylen, FW Crawford, M Callens, F De Smet, ...
Scientific reports 5 (1), 18585, 2015
552015
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20